Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up

Journal of Hepatology
Hiromi YatsujiHiromitsu Kumada

Abstract

We studied the long-term efficacy (median follow-up of 28 months) of adefovir (ADV) in combination with lamivudine (LAM) in 132 LAM-resistant Japanese patients with chronic genotype C-dominant hepatitis B virus (HBV) infection. The viral response (undetectable HBV-DNA by PCR assay) and the predictor of viral response were evaluated. The emergence of ADV-resistant mutants was investigated during the combination therapy. The cumulative probability of viral response was 69% at 12 months, and 81% at 24 months. Multivariate analysis identified baseline HBe antigen status (P=0.0001), aspartate aminotransferase level (AST) (P=0.001) and HBV-DNA level (P=0.002) as determinants of viral response to treatment. At the beginning of ADV therapy, substitutions at rtA181 (rtA181T and rtA181S) were identified in 3 patients (2.3%). In the remaining 129 patients, the rtM204 mutants were identified at baseline, and two (1.6%) of the 129 patients developed new ADV-resistant mutants; one was rtA181S and another was rtA181T plus rtN236T mutation. Adefovir and lamivudine combination therapy effectively suppressed viral replication and maintained the efficacy well in LAM-resistant patients with chronic HBV infection. Genotypic analysis indicated that ...Continue Reading

References

Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M I AllenL D Condreay
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C T YehY F Liaw
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ching-Lung LaiLynn Condreay
Mar 12, 2004·The New England Journal of Medicine·Don Ganem, Alfred M Prince
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florian van BömmelThomas Berg
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marie-Noëlle BrunelleFabien Zoulim
Dec 1, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pietro LamperticoMassimo Colombo
May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yoon-Seon LeeSoo-Ok Kim
Jun 10, 2006·Gastroenterology·Morris ShermanUNKNOWN AI463026 BEHoLD Study Group
Jul 28, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florian van BömmelThomas Berg
Sep 20, 2006·Antimicrobial Agents and Chemotherapy·Hiromi YatsujiKazuaki Chayama
Nov 8, 2006·Gastroenterology·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard J ColonnoDaniel J Tenney
Jan 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Irene RaptiStephanos J Hadziyannis

❮ Previous
Next ❯

Citations

Jun 1, 2012·Hepatology International·Yun-Fan LiawMasao Omata
Oct 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Debika Bhattacharya, Chloe L Thio
Feb 20, 2009·Journal of Gastroenterology and Hepatology·Yoshiyuki SuzukiHiromitsu Kumada
Jan 16, 2010·Journal of Gastroenterology and Hepatology·Kazuhiko HayashiHidemi Goto
Dec 16, 2011·Journal of Gastroenterology and Hepatology·Yu Jin KimByung Chul Yoo
Jun 15, 2012·Journal of Gastroenterology and Hepatology·Cheng WangJinlin Hou
Sep 2, 2011·Digestive Diseases and Sciences·Marco MontagnaniGiuseppe Mazzella
Oct 27, 2009·Expert Opinion on Investigational Drugs·Ivana Carey, Phillip M Harrison
Jun 16, 2011·Expert Opinion on Drug Safety·Mauro ViganòMassimo Colombo
Sep 22, 2015·Viruses·Lei KangJing Tang
Jun 22, 2013·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chih-Lin Lin, Jia-Horng Kao
Oct 19, 2010·Journal of Virological Methods·Kenichi TadokoroHiromitsu Kumada
Oct 31, 2015·The Journal of Infection·Eisuke MurakamiKazuaki Chayama
Apr 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norah A Terrault
Oct 2, 2009·Pharmacotherapy·Alice M JenhPaul A Pham
Jan 20, 2009·Journal of Medical Virology·H L ZaaijerR Molenkamp
Sep 16, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Tetsuya HosakaHiromitsu Kumada
Dec 20, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Waka Ohishi, Kazuaki Chayama
May 25, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masashi NinomiyaTooru Shimosegawa
Oct 1, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tetsuya HosakaHiromitsu Kumada
Feb 18, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Patrick MarcellinTeerha Piratvisuth
Jan 9, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·UNKNOWN Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology
Feb 17, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hiromitsu KumadaUNKNOWN Study Group for the Standardization of Treatment of Viral Hepatitis Including Cirrhosis, Ministry of Health, Labor and Welfa
Nov 20, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hiromitsu KumadaWataru Sugiura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.